If JP was so good, why no update on ph3 approval? The man literally said post FDA meeting he hoped for FDA alignment on endpoints by Christmas. Since then he's gone on a podcast talking in a different tone talking about how hard alignment will be to reach. And here we are at Christmas and no alignment, no indication of when alignment might occur.
NEU Price at posting:
$12.20 Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)